Key highlights

  • Wesfarmers reported FY26 Revenue of A$47,274 million, up 3.4%, and NPAT of A$2,874 million, down 1.8%, on 27 August 2026.
  • Excluding prior-year significant items, NPAT rose 8.3% and EBIT rose 7.3% to A$4,493 million.
  • The full-year ordinary Dividend was 222 cents per share fully franked, up 7.8%.

Wesfarmers Limited (ASX:WES) released its 2026 full-year results on 27 August 2026 for the year ended 30 June 2026. The release covered group earnings, dividends and the performance of divisions including Bunnings, Kmart Group, WesCEF, Officeworks and Wesfarmers Health, along with an outlook.

About Wesfarmers

Wesfarmers is a diversified Australian company. Its businesses include the Bunnings home improvement chain, Kmart Group, Officeworks, Wesfarmers Health, and WesCEF, which covers chemicals, energy and fertilisers and includes a lithium business.

Group results

Revenue was A$47,274 million, up 3.4%. EBIT was A$4,493 million, up 0.6%, or up 7.3% excluding prior-year significant items. NPAT was A$2,874 million, down 1.8%, or up 8.3% excluding significant items, and basic EPS was 253.4 cents. There were no significant items in 2026, while 2025 included A$279 million relating to the Coregas gain on sale, the wind-up of a property structure and costs associated with the wind-down of Catch.

Operating cash flow was A$4,272 million, down 6.5%. The company said higher inventories in WesCEF and Health affected cash flow, including spodumene inventories and fertiliser inventory at elevated prices due to Middle East Supply disruptions. The full-year ordinary dividend was 222 cents per share, fully franked, up 7.8%.

Retail divisions

The company said Bunnings and Kmart Group delivered growth supported by everyday low prices, productivity initiatives and operating leverage, and that retail businesses dropped prices on thousands of products during the year. Kmart Earnings were supported by its Anko products and cost control, and digital sales accelerated. Officeworks earnings reflected one-off costs related to its transformation program, which began in the first half of FY26.

Wesfarmers Health delivered higher earnings as its multi-year transformation gained momentum, and the retail media network continued to scale.

WesCEF and lithium

WesCEF earnings were affected by the timing of higher ammonia prices linked to the Middle East conflict, while the division benefited from operational performance and an improved contribution from its lithium business. Spodumene concentrate production was 209 kilotonnes, above both guidance and nameplate capacity. Ramp-up of the lithium refinery was affected by intermittent odour issues during the year, and mitigation measures began to be installed late in FY26.

Risks to consider

Operating cash flow fell 6.5%, and statutory NPAT was lower than in FY25 because the earlier year included significant items. The company referred to uncertainty regarding inflation, house prices, interest rates and cost of living pressures on households.

The lithium refinery ramp-up was affected by odour issues, and commodity-linked earnings at WesCEF depend on ammonia and spodumene prices. Officeworks incurred one-off transformation costs, and retail price cuts can reduce margins.

Catalysts to watch

Items to watch include the first weeks of FY27 trading for Bunnings and Kmart, completion of odour mitigation at the lithium refinery, Officeworks transformation delivery, Wesfarmers Health growth, and Commodity prices.